S
LLY icon

SignatureFD’s Eli Lilly LLY Stock Holding History

SignatureFD’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6M Buy
25,699
+102
+0.4% +$103K 0.36% 33
2025
Q4 		$27.5M Buy
25,597
+469
+2% +$448K 0.42% 29
2025
Q3 		$19.2M Buy
25,128
+73
+0.3% +$54.3K 0.3% 32
2025
Q2 		$19.5M Sell
25,055
-632
-2% -$491K 0.33% 31
2025
Q1 		$21.2M Buy
25,687
+367
+1% +$305K 0.4% 31
2024
Q4 		$19.5M Sell
25,320
-505
-2% -$418K 0.37% 29
2024
Q3 		$22.9M Sell
25,825
-4
-0% -$3.6K 0.44% 29
2024
Q2 		$23.4M Buy
25,829
+302
+1% +$242K 0.48% 28
2024
Q1 		$19.9M Buy
25,527
+1,554
+6% +$1.11M 0.42% 29
2023
Q4 		$14M Buy
23,973
+598
+3% +$349K 0.32% 31
2023
Q3 		$12.6M Buy
23,375
+457
+2% +$235K 0.33% 32
2023
Q2 		$10.7M Buy
22,918
+717
+3% +$301K 0.27% 33
2023
Q1 		$7.62M Sell
22,201
-336
-1% -$113K 0.21% 41
2022
Q4 		$8.25M Buy
22,537
+622
+3% +$221K 0.24% 33
2022
Q3 		$7.09M Buy
21,915
+253
+1% +$80.2K 0.24% 33
2022
Q2 		$7.02M Buy
21,662
+1,244
+6% +$373K 0.24% 34
2022
Q1 		$5.85M Sell
20,418
-82
-0.4% -$21.1K 0.18% 47
2021
Q4 		$5.66M Buy
20,500
+2,023
+11% +$513K 0.17% 47
2021
Q3 		$4.27M Buy
18,477
+1,761
+11% +$435K 0.15% 52
2021
Q2 		$3.84M Buy
16,716
+231
+1% +$46.4K 0.15% 50
2021
Q1 		$3.08M Buy
16,485
+953
+6% +$186K 0.14% 59
2020
Q4 		$2.62M Sell
15,532
-3,952
-20% -$590K 0.12% 58
2020
Q3 		$2.88M Buy
19,484
+5,427
+39% +$840K 0.15% 51
2020
Q2 		$2.31M Sell
14,057
-113
-0.8% -$17.3K 0.14% 53
2020
Q1 		$1.97M Buy
14,170
+5
+0% +$687 0.17% 53
2019
Q4 		$1.86M Buy
14,165
+7,527
+113% +$872K 0.14% 61
2019
Q3 		$742K Buy
6,638
+302
+5% +$33.6K 0.06% 132
2019
Q2 		$702K Sell
6,336
-988
-13% -$116K 0.06% 128
2019
Q1 		$950K Buy
7,324
+142
+2% +$17.3K 0.08% 93
2018
Q4 		$831K Buy
7,182
+1,838
+34% +$205K 0.08% 101
2018
Q3 		$573K Buy
5,344
+254
+5% +$25.4K 0.06% 171
2018
Q2 		$434K Buy
5,090
+759
+18% +$62.3K 0.05% 203
2018
Q1 		$335K Sell
4,331
-824
-16% -$66.3K 0.04% 213
2017
Q4 		$435K Buy
5,155
+2,086
+68% +$177K 0.05% 169
2017
Q3 		$263K Buy
3,069
+136
+5% +$11.2K 0.03% 230
2017
Q2 		$241K Sell
2,933
-362
-11% -$29.5K 0.04% 227
2017
Q1 		$277K Buy
+3,295
New +$264K 0.04% 208
2016
Q4 		– Sell
-2,031
Closed -$163K – 784
2016
Q3 		$163K Buy
2,031
+235
+13% +$18.8K 0.02% 264
2016
Q2 		$141K Buy
1,796
+249
+16% +$18.7K 0.02% 232
2016
Q1 		$111K Sell
1,547
-108
-7% -$8.17K 0.02% 247
2015
Q4 		$139K Buy
1,655
+195
+13% +$16.2K 0.03% 187
2015
Q3 		$122K Buy
1,460
+377
+35% +$31.8K 0.03% 185
2015
Q2 		$90K Buy
1,083
+589
+119% +$44.9K 0.02% 251
2015
Q1 		$36K Buy
494
+77
+18% +$5.48K 0.01% 356
2014
Q4 		$29K Sell
417
-1,412
-77% -$95.3K 0.01% 362
2014
Q3 		$119K Buy
1,829
+1,572
+612% +$99.5K 0.04% 158
2014
Q2 		$16K Sell
257
-4,485
-95% -$268K 0.01% 393
2014
Q1 		$279K Buy
4,742
+179
+4% +$9.99K 0.11% 58
2013
Q4 		$233K Buy
4,563
+1,080
+31% +$54.1K 0.08% 74
2013
Q3 		$175K Buy
3,483
+1,668
+92% +$87.3K 0.07% 84
2013
Q2 		$89K Buy
+1,815
New +$98.8K 0.05% 125

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SignatureFD's LLY Position: Q1 2026 in Review

SignatureFD increased its Eli Lilly (LLY) stake by 0.4% in Q1 2026, buying an estimated $103K and bringing the position to 25,699 shares worth $23.6M. The position accounts for 0.36% of the portfolio, ranked #33.

SignatureFD first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $27.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SignatureFD held 25,699 shares of Eli Lilly worth $23.6M as of Q1 2026.
  • SignatureFD bought 102 Eli Lilly shares in Q1 2026, an estimated $103K.
  • Eli Lilly made up 0.36% of SignatureFD's portfolio in Q1 2026, its #33 holding.
  • SignatureFD first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • SignatureFD's Eli Lilly position peaked at $27.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.